Global Candesartan Cilexetil Tablets Market Research Report 2023

Publisher Name :
Date: 26-Jan-2023
No. of pages: 109
Inquire Before Buying

Highlights

The global Candesartan Cilexetil Tablets market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Candesartan Cilexetil Tablets is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Candesartan Cilexetil Tablets is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Candesartan Cilexetil Tablets include Takeda, Viatris (Mylan), Apotex, AstraZeneca, Alembic Pharmaceuticals, Zydus Lifesciences, Cheplapharm Arzneimittel, ANI Pharmaceuticals and Chongqing Shenghuaxi Pharm, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Candesartan Cilexetil Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Candesartan Cilexetil Tablets.

The Candesartan Cilexetil Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Candesartan Cilexetil Tablets market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Candesartan Cilexetil Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

By Company

- Takeda

- Viatris (Mylan)

- Apotex

- AstraZeneca

- Alembic Pharmaceuticals

- Zydus Lifesciences

- Cheplapharm Arzneimittel

- ANI Pharmaceuticals

- Chongqing Shenghuaxi Pharm

- Tianjin Institute of Pharmaceutical Research

- Hainan Helpson Medicine & Biotechnique

- Disha Pharmaceutical Group

- Zhejiang Yongning Pharmaceutical

- Sihuan Pharmaceutical

- The United Laboratories Limited

- Guangzhou Baiyunshan Tianxin Pharmaceutical

Segment by Type

- 4mg Tablets

- 8mg Tablets

- 16mg Tablets

- 32mg Tablets

- Others

Segment by Application

- Essential Hypertension

- Others

Consumption by Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Candesartan Cilexetil Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Candesartan Cilexetil Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Global Candesartan Cilexetil Tablets Market Research Report 2023

Table of Contents
1 Candesartan Cilexetil Tablets Market Overview
1.1 Product Overview and Scope of Candesartan Cilexetil Tablets
1.2 Candesartan Cilexetil Tablets Segment by Type
1.2.1 Global Candesartan Cilexetil Tablets Market Value Comparison by Type (2023-2029)
1.2.2 4mg Tablets
1.2.3 8mg Tablets
1.2.4 16mg Tablets
1.2.5 32mg Tablets
1.2.6 Others
1.3 Candesartan Cilexetil Tablets Segment by Application
1.3.1 Global Candesartan Cilexetil Tablets Market Value by Application: (2023-2029)
1.3.2 Essential Hypertension
1.3.3 Others
1.4 Global Candesartan Cilexetil Tablets Market Size Estimates and Forecasts
1.4.1 Global Candesartan Cilexetil Tablets Revenue 2018-2029
1.4.2 Global Candesartan Cilexetil Tablets Sales 2018-2029
1.4.3 Global Candesartan Cilexetil Tablets Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Candesartan Cilexetil Tablets Market Competition by Manufacturers
2.1 Global Candesartan Cilexetil Tablets Sales Market Share by Manufacturers (2018-2023)
2.2 Global Candesartan Cilexetil Tablets Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Candesartan Cilexetil Tablets Average Price by Manufacturers (2018-2023)
2.4 Global Candesartan Cilexetil Tablets Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Candesartan Cilexetil Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Candesartan Cilexetil Tablets, Product Type & Application
2.7 Candesartan Cilexetil Tablets Market Competitive Situation and Trends
2.7.1 Candesartan Cilexetil Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Candesartan Cilexetil Tablets Players Market Share by Revenue
2.7.3 Global Candesartan Cilexetil Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Candesartan Cilexetil Tablets Retrospective Market Scenario by Region
3.1 Global Candesartan Cilexetil Tablets Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Candesartan Cilexetil Tablets Global Candesartan Cilexetil Tablets Sales by Region: 2018-2029
3.2.1 Global Candesartan Cilexetil Tablets Sales by Region: 2018-2023
3.2.2 Global Candesartan Cilexetil Tablets Sales by Region: 2024-2029
3.3 Global Candesartan Cilexetil Tablets Global Candesartan Cilexetil Tablets Revenue by Region: 2018-2029
3.3.1 Global Candesartan Cilexetil Tablets Revenue by Region: 2018-2023
3.3.2 Global Candesartan Cilexetil Tablets Revenue by Region: 2024-2029
3.4 North America Candesartan Cilexetil Tablets Market Facts & Figures by Country
3.4.1 North America Candesartan Cilexetil Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Candesartan Cilexetil Tablets Sales by Country (2018-2029)
3.4.3 North America Candesartan Cilexetil Tablets Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Candesartan Cilexetil Tablets Market Facts & Figures by Country
3.5.1 Europe Candesartan Cilexetil Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Candesartan Cilexetil Tablets Sales by Country (2018-2029)
3.5.3 Europe Candesartan Cilexetil Tablets Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Candesartan Cilexetil Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Candesartan Cilexetil Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Candesartan Cilexetil Tablets Sales by Country (2018-2029)
3.6.3 Asia Pacific Candesartan Cilexetil Tablets Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Candesartan Cilexetil Tablets Market Facts & Figures by Country
3.7.1 Latin America Candesartan Cilexetil Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Candesartan Cilexetil Tablets Sales by Country (2018-2029)
3.7.3 Latin America Candesartan Cilexetil Tablets Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Candesartan Cilexetil Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Candesartan Cilexetil Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Candesartan Cilexetil Tablets Sales by Country (2018-2029)
3.8.3 Middle East and Africa Candesartan Cilexetil Tablets Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Candesartan Cilexetil Tablets Sales by Type (2018-2029)
4.1.1 Global Candesartan Cilexetil Tablets Sales by Type (2018-2023)
4.1.2 Global Candesartan Cilexetil Tablets Sales by Type (2024-2029)
4.1.3 Global Candesartan Cilexetil Tablets Sales Market Share by Type (2018-2029)
4.2 Global Candesartan Cilexetil Tablets Revenue by Type (2018-2029)
4.2.1 Global Candesartan Cilexetil Tablets Revenue by Type (2018-2023)
4.2.2 Global Candesartan Cilexetil Tablets Revenue by Type (2024-2029)
4.2.3 Global Candesartan Cilexetil Tablets Revenue Market Share by Type (2018-2029)
4.3 Global Candesartan Cilexetil Tablets Price by Type (2018-2029)
5 Segment by Application
5.1 Global Candesartan Cilexetil Tablets Sales by Application (2018-2029)
5.1.1 Global Candesartan Cilexetil Tablets Sales by Application (2018-2023)
5.1.2 Global Candesartan Cilexetil Tablets Sales by Application (2024-2029)
5.1.3 Global Candesartan Cilexetil Tablets Sales Market Share by Application (2018-2029)
5.2 Global Candesartan Cilexetil Tablets Revenue by Application (2018-2029)
5.2.1 Global Candesartan Cilexetil Tablets Revenue by Application (2018-2023)
5.2.2 Global Candesartan Cilexetil Tablets Revenue by Application (2024-2029)
5.2.3 Global Candesartan Cilexetil Tablets Revenue Market Share by Application (2018-2029)
5.3 Global Candesartan Cilexetil Tablets Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Candesartan Cilexetil Tablets Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Takeda Candesartan Cilexetil Tablets Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Viatris (Mylan)
6.2.1 Viatris (Mylan) Corporation Information
6.2.2 Viatris (Mylan) Description and Business Overview
6.2.3 Viatris (Mylan) Candesartan Cilexetil Tablets Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Viatris (Mylan) Candesartan Cilexetil Tablets Product Portfolio
6.2.5 Viatris (Mylan) Recent Developments/Updates
6.3 Apotex
6.3.1 Apotex Corporation Information
6.3.2 Apotex Description and Business Overview
6.3.3 Apotex Candesartan Cilexetil Tablets Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Apotex Candesartan Cilexetil Tablets Product Portfolio
6.3.5 Apotex Recent Developments/Updates
6.4 AstraZeneca
6.4.1 AstraZeneca Corporation Information
6.4.2 AstraZeneca Description and Business Overview
6.4.3 AstraZeneca Candesartan Cilexetil Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 AstraZeneca Candesartan Cilexetil Tablets Product Portfolio
6.4.5 AstraZeneca Recent Developments/Updates
6.5 Alembic Pharmaceuticals
6.5.1 Alembic Pharmaceuticals Corporation Information
6.5.2 Alembic Pharmaceuticals Description and Business Overview
6.5.3 Alembic Pharmaceuticals Candesartan Cilexetil Tablets Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Alembic Pharmaceuticals Candesartan Cilexetil Tablets Product Portfolio
6.5.5 Alembic Pharmaceuticals Recent Developments/Updates
6.6 Zydus Lifesciences
6.6.1 Zydus Lifesciences Corporation Information
6.6.2 Zydus Lifesciences Description and Business Overview
6.6.3 Zydus Lifesciences Candesartan Cilexetil Tablets Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Zydus Lifesciences Candesartan Cilexetil Tablets Product Portfolio
6.6.5 Zydus Lifesciences Recent Developments/Updates
6.7 Cheplapharm Arzneimittel
6.6.1 Cheplapharm Arzneimittel Corporation Information
6.6.2 Cheplapharm Arzneimittel Description and Business Overview
6.6.3 Cheplapharm Arzneimittel Candesartan Cilexetil Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Cheplapharm Arzneimittel Candesartan Cilexetil Tablets Product Portfolio
6.7.5 Cheplapharm Arzneimittel Recent Developments/Updates
6.8 ANI Pharmaceuticals
6.8.1 ANI Pharmaceuticals Corporation Information
6.8.2 ANI Pharmaceuticals Description and Business Overview
6.8.3 ANI Pharmaceuticals Candesartan Cilexetil Tablets Sales, Revenue and Gross Margin (2018-2023)
6.8.4 ANI Pharmaceuticals Candesartan Cilexetil Tablets Product Portfolio
6.8.5 ANI Pharmaceuticals Recent Developments/Updates
6.9 Chongqing Shenghuaxi Pharm
6.9.1 Chongqing Shenghuaxi Pharm Corporation Information
6.9.2 Chongqing Shenghuaxi Pharm Description and Business Overview
6.9.3 Chongqing Shenghuaxi Pharm Candesartan Cilexetil Tablets Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Chongqing Shenghuaxi Pharm Candesartan Cilexetil Tablets Product Portfolio
6.9.5 Chongqing Shenghuaxi Pharm Recent Developments/Updates
6.10 Tianjin Institute of Pharmaceutical Research
6.10.1 Tianjin Institute of Pharmaceutical Research Corporation Information
6.10.2 Tianjin Institute of Pharmaceutical Research Description and Business Overview
6.10.3 Tianjin Institute of Pharmaceutical Research Candesartan Cilexetil Tablets Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Tianjin Institute of Pharmaceutical Research Candesartan Cilexetil Tablets Product Portfolio
6.10.5 Tianjin Institute of Pharmaceutical Research Recent Developments/Updates
6.11 Hainan Helpson Medicine & Biotechnique
6.11.1 Hainan Helpson Medicine & Biotechnique Corporation Information
6.11.2 Hainan Helpson Medicine & Biotechnique Candesartan Cilexetil Tablets Description and Business Overview
6.11.3 Hainan Helpson Medicine & Biotechnique Candesartan Cilexetil Tablets Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Hainan Helpson Medicine & Biotechnique Candesartan Cilexetil Tablets Product Portfolio
6.11.5 Hainan Helpson Medicine & Biotechnique Recent Developments/Updates
6.12 Disha Pharmaceutical Group
6.12.1 Disha Pharmaceutical Group Corporation Information
6.12.2 Disha Pharmaceutical Group Candesartan Cilexetil Tablets Description and Business Overview
6.12.3 Disha Pharmaceutical Group Candesartan Cilexetil Tablets Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Disha Pharmaceutical Group Candesartan Cilexetil Tablets Product Portfolio
6.12.5 Disha Pharmaceutical Group Recent Developments/Updates
6.13 Zhejiang Yongning Pharmaceutical
6.13.1 Zhejiang Yongning Pharmaceutical Corporation Information
6.13.2 Zhejiang Yongning Pharmaceutical Candesartan Cilexetil Tablets Description and Business Overview
6.13.3 Zhejiang Yongning Pharmaceutical Candesartan Cilexetil Tablets Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Zhejiang Yongning Pharmaceutical Candesartan Cilexetil Tablets Product Portfolio
6.13.5 Zhejiang Yongning Pharmaceutical Recent Developments/Updates
6.14 Sihuan Pharmaceutical
6.14.1 Sihuan Pharmaceutical Corporation Information
6.14.2 Sihuan Pharmaceutical Candesartan Cilexetil Tablets Description and Business Overview
6.14.3 Sihuan Pharmaceutical Candesartan Cilexetil Tablets Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Sihuan Pharmaceutical Candesartan Cilexetil Tablets Product Portfolio
6.14.5 Sihuan Pharmaceutical Recent Developments/Updates
6.15 The United Laboratories Limited
6.15.1 The United Laboratories Limited Corporation Information
6.15.2 The United Laboratories Limited Candesartan Cilexetil Tablets Description and Business Overview
6.15.3 The United Laboratories Limited Candesartan Cilexetil Tablets Sales, Revenue and Gross Margin (2018-2023)
6.15.4 The United Laboratories Limited Candesartan Cilexetil Tablets Product Portfolio
6.15.5 The United Laboratories Limited Recent Developments/Updates
6.16 Guangzhou Baiyunshan Tianxin Pharmaceutical
6.16.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Corporation Information
6.16.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Candesartan Cilexetil Tablets Description and Business Overview
6.16.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Candesartan Cilexetil Tablets Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Candesartan Cilexetil Tablets Product Portfolio
6.16.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Candesartan Cilexetil Tablets Industry Chain Analysis
7.2 Candesartan Cilexetil Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Candesartan Cilexetil Tablets Production Mode & Process
7.4 Candesartan Cilexetil Tablets Sales and Marketing
7.4.1 Candesartan Cilexetil Tablets Sales Channels
7.4.2 Candesartan Cilexetil Tablets Distributors
7.5 Candesartan Cilexetil Tablets Customers
8 Candesartan Cilexetil Tablets Market Dynamics
8.1 Candesartan Cilexetil Tablets Industry Trends
8.2 Candesartan Cilexetil Tablets Market Drivers
8.3 Candesartan Cilexetil Tablets Market Challenges
8.4 Candesartan Cilexetil Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Candesartan Cilexetil Tablets Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Candesartan Cilexetil Tablets Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Candesartan Cilexetil Tablets Market Competitive Situation by Manufacturers in 2022
Table 4. Global Candesartan Cilexetil Tablets Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Candesartan Cilexetil Tablets Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Candesartan Cilexetil Tablets Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Candesartan Cilexetil Tablets Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Candesartan Cilexetil Tablets Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Candesartan Cilexetil Tablets, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Candesartan Cilexetil Tablets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Candesartan Cilexetil Tablets, Product Type & Application
Table 12. Global Key Manufacturers of Candesartan Cilexetil Tablets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Candesartan Cilexetil Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Candesartan Cilexetil Tablets as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Candesartan Cilexetil Tablets Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Candesartan Cilexetil Tablets Sales by Region (2018-2023) & (K Units)
Table 18. Global Candesartan Cilexetil Tablets Sales Market Share by Region (2018-2023)
Table 19. Global Candesartan Cilexetil Tablets Sales by Region (2024-2029) & (K Units)
Table 20. Global Candesartan Cilexetil Tablets Sales Market Share by Region (2024-2029)
Table 21. Global Candesartan Cilexetil Tablets Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Candesartan Cilexetil Tablets Revenue Market Share by Region (2018-2023)
Table 23. Global Candesartan Cilexetil Tablets Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Candesartan Cilexetil Tablets Revenue Market Share by Region (2024-2029)
Table 25. North America Candesartan Cilexetil Tablets Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Candesartan Cilexetil Tablets Sales by Country (2018-2023) & (K Units)
Table 27. North America Candesartan Cilexetil Tablets Sales by Country (2024-2029) & (K Units)
Table 28. North America Candesartan Cilexetil Tablets Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Candesartan Cilexetil Tablets Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Candesartan Cilexetil Tablets Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Candesartan Cilexetil Tablets Sales by Country (2018-2023) & (K Units)
Table 32. Europe Candesartan Cilexetil Tablets Sales by Country (2024-2029) & (K Units)
Table 33. Europe Candesartan Cilexetil Tablets Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Candesartan Cilexetil Tablets Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Candesartan Cilexetil Tablets Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Candesartan Cilexetil Tablets Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Candesartan Cilexetil Tablets Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Candesartan Cilexetil Tablets Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Candesartan Cilexetil Tablets Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Candesartan Cilexetil Tablets Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Candesartan Cilexetil Tablets Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Candesartan Cilexetil Tablets Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Candesartan Cilexetil Tablets Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Candesartan Cilexetil Tablets Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Candesartan Cilexetil Tablets Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Candesartan Cilexetil Tablets Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Candesartan Cilexetil Tablets Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Candesartan Cilexetil Tablets Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Candesartan Cilexetil Tablets Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Candesartan Cilexetil Tablets Sales (K Units) by Type (2018-2023)
Table 51. Global Candesartan Cilexetil Tablets Sales (K Units) by Type (2024-2029)
Table 52. Global Candesartan Cilexetil Tablets Sales Market Share by Type (2018-2023)
Table 53. Global Candesartan Cilexetil Tablets Sales Market Share by Type (2024-2029)
Table 54. Global Candesartan Cilexetil Tablets Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Candesartan Cilexetil Tablets Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Candesartan Cilexetil Tablets Revenue Market Share by Type (2018-2023)
Table 57. Global Candesartan Cilexetil Tablets Revenue Market Share by Type (2024-2029)
Table 58. Global Candesartan Cilexetil Tablets Price (US$/Unit) by Type (2018-2023)
Table 59. Global Candesartan Cilexetil Tablets Price (US$/Unit) by Type (2024-2029)
Table 60. Global Candesartan Cilexetil Tablets Sales (K Units) by Application (2018-2023)
Table 61. Global Candesartan Cilexetil Tablets Sales (K Units) by Application (2024-2029)
Table 62. Global Candesartan Cilexetil Tablets Sales Market Share by Application (2018-2023)
Table 63. Global Candesartan Cilexetil Tablets Sales Market Share by Application (2024-2029)
Table 64. Global Candesartan Cilexetil Tablets Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Candesartan Cilexetil Tablets Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Candesartan Cilexetil Tablets Revenue Market Share by Application (2018-2023)
Table 67. Global Candesartan Cilexetil Tablets Revenue Market Share by Application (2024-2029)
Table 68. Global Candesartan Cilexetil Tablets Price (US$/Unit) by Application (2018-2023)
Table 69. Global Candesartan Cilexetil Tablets Price (US$/Unit) by Application (2024-2029)
Table 70. Takeda Corporation Information
Table 71. Takeda Description and Business Overview
Table 72. Takeda Candesartan Cilexetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Takeda Candesartan Cilexetil Tablets Product
Table 74. Takeda Recent Developments/Updates
Table 75. Viatris (Mylan) Corporation Information
Table 76. Viatris (Mylan) Description and Business Overview
Table 77. Viatris (Mylan) Candesartan Cilexetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Viatris (Mylan) Candesartan Cilexetil Tablets Product
Table 79. Viatris (Mylan) Recent Developments/Updates
Table 80. Apotex Corporation Information
Table 81. Apotex Description and Business Overview
Table 82. Apotex Candesartan Cilexetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Apotex Candesartan Cilexetil Tablets Product
Table 84. Apotex Recent Developments/Updates
Table 85. AstraZeneca Corporation Information
Table 86. AstraZeneca Description and Business Overview
Table 87. AstraZeneca Candesartan Cilexetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. AstraZeneca Candesartan Cilexetil Tablets Product
Table 89. AstraZeneca Recent Developments/Updates
Table 90. Alembic Pharmaceuticals Corporation Information
Table 91. Alembic Pharmaceuticals Description and Business Overview
Table 92. Alembic Pharmaceuticals Candesartan Cilexetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Alembic Pharmaceuticals Candesartan Cilexetil Tablets Product
Table 94. Alembic Pharmaceuticals Recent Developments/Updates
Table 95. Zydus Lifesciences Corporation Information
Table 96. Zydus Lifesciences Description and Business Overview
Table 97. Zydus Lifesciences Candesartan Cilexetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Zydus Lifesciences Candesartan Cilexetil Tablets Product
Table 99. Zydus Lifesciences Recent Developments/Updates
Table 100. Cheplapharm Arzneimittel Corporation Information
Table 101. Cheplapharm Arzneimittel Description and Business Overview
Table 102. Cheplapharm Arzneimittel Candesartan Cilexetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Cheplapharm Arzneimittel Candesartan Cilexetil Tablets Product
Table 104. Cheplapharm Arzneimittel Recent Developments/Updates
Table 105. ANI Pharmaceuticals Corporation Information
Table 106. ANI Pharmaceuticals Description and Business Overview
Table 107. ANI Pharmaceuticals Candesartan Cilexetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. ANI Pharmaceuticals Candesartan Cilexetil Tablets Product
Table 109. ANI Pharmaceuticals Recent Developments/Updates
Table 110. Chongqing Shenghuaxi Pharm Corporation Information
Table 111. Chongqing Shenghuaxi Pharm Description and Business Overview
Table 112. Chongqing Shenghuaxi Pharm Candesartan Cilexetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Chongqing Shenghuaxi Pharm Candesartan Cilexetil Tablets Product
Table 114. Chongqing Shenghuaxi Pharm Recent Developments/Updates
Table 115. Tianjin Institute of Pharmaceutical Research Corporation Information
Table 116. Tianjin Institute of Pharmaceutical Research Description and Business Overview
Table 117. Tianjin Institute of Pharmaceutical Research Candesartan Cilexetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Tianjin Institute of Pharmaceutical Research Candesartan Cilexetil Tablets Product
Table 119. Tianjin Institute of Pharmaceutical Research Recent Developments/Updates
Table 120. Hainan Helpson Medicine & Biotechnique Corporation Information
Table 121. Hainan Helpson Medicine & Biotechnique Description and Business Overview
Table 122. Hainan Helpson Medicine & Biotechnique Candesartan Cilexetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Hainan Helpson Medicine & Biotechnique Candesartan Cilexetil Tablets Product
Table 124. Hainan Helpson Medicine & Biotechnique Recent Developments/Updates
Table 125. Disha Pharmaceutical Group Corporation Information
Table 126. Disha Pharmaceutical Group Description and Business Overview
Table 127. Disha Pharmaceutical Group Candesartan Cilexetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Disha Pharmaceutical Group Candesartan Cilexetil Tablets Product
Table 129. Disha Pharmaceutical Group Recent Developments/Updates
Table 130. Zhejiang Yongning Pharmaceutical Corporation Information
Table 131. Zhejiang Yongning Pharmaceutical Description and Business Overview
Table 132. Zhejiang Yongning Pharmaceutical Candesartan Cilexetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Zhejiang Yongning Pharmaceutical Candesartan Cilexetil Tablets Product
Table 134. Zhejiang Yongning Pharmaceutical Recent Developments/Updates
Table 135. Sihuan Pharmaceutical Corporation Information
Table 136. Sihuan Pharmaceutical Description and Business Overview
Table 137. Sihuan Pharmaceutical Candesartan Cilexetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Sihuan Pharmaceutical Candesartan Cilexetil Tablets Product
Table 139. Sihuan Pharmaceutical Recent Developments/Updates
Table 140. The United Laboratories Limited Corporation Information
Table 141. The United Laboratories Limited Description and Business Overview
Table 142. The United Laboratories Limited Candesartan Cilexetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. The United Laboratories Limited Candesartan Cilexetil Tablets Product
Table 144. The United Laboratories Limited Recent Developments/Updates
Table 145. Guangzhou Baiyunshan Tianxin Pharmaceutical Corporation Information
Table 146. Guangzhou Baiyunshan Tianxin Pharmaceutical Description and Business Overview
Table 147. Guangzhou Baiyunshan Tianxin Pharmaceutical Candesartan Cilexetil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Guangzhou Baiyunshan Tianxin Pharmaceutical Candesartan Cilexetil Tablets Product
Table 149. Guangzhou Baiyunshan Tianxin Pharmaceutical Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Candesartan Cilexetil Tablets Distributors List
Table 153. Candesartan Cilexetil Tablets Customers List
Table 154. Candesartan Cilexetil Tablets Market Trends
Table 155. Candesartan Cilexetil Tablets Market Drivers
Table 156. Candesartan Cilexetil Tablets Market Challenges
Table 157. Candesartan Cilexetil Tablets Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Candesartan Cilexetil Tablets
Figure 2. Global Candesartan Cilexetil Tablets Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Candesartan Cilexetil Tablets Market Share by Type in 2022 & 2029
Figure 4. 4mg Tablets Product Picture
Figure 5. 8mg Tablets Product Picture
Figure 6. 16mg Tablets Product Picture
Figure 7. 32mg Tablets Product Picture
Figure 8. Others Product Picture
Figure 9. Global Candesartan Cilexetil Tablets Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 10. Global Candesartan Cilexetil Tablets Market Share by Application in 2022 & 2029
Figure 11. Essential Hypertension
Figure 12. Others
Figure 13. Global Candesartan Cilexetil Tablets Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Candesartan Cilexetil Tablets Market Size (2018-2029) & (US$ Million)
Figure 15. Global Candesartan Cilexetil Tablets Sales (2018-2029) & (K Units)
Figure 16. Global Candesartan Cilexetil Tablets Average Price (US$/Unit) & (2018-2029)
Figure 17. Candesartan Cilexetil Tablets Report Years Considered
Figure 18. Candesartan Cilexetil Tablets Sales Share by Manufacturers in 2022
Figure 19. Global Candesartan Cilexetil Tablets Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Candesartan Cilexetil Tablets Players: Market Share by Revenue in 2022
Figure 21. Candesartan Cilexetil Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Candesartan Cilexetil Tablets Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Candesartan Cilexetil Tablets Sales Market Share by Country (2018-2029)
Figure 24. North America Candesartan Cilexetil Tablets Revenue Market Share by Country (2018-2029)
Figure 25. United States Candesartan Cilexetil Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Candesartan Cilexetil Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Candesartan Cilexetil Tablets Sales Market Share by Country (2018-2029)
Figure 28. Europe Candesartan Cilexetil Tablets Revenue Market Share by Country (2018-2029)
Figure 29. Germany Candesartan Cilexetil Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Candesartan Cilexetil Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Candesartan Cilexetil Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Candesartan Cilexetil Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Candesartan Cilexetil Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Candesartan Cilexetil Tablets Sales Market Share by R
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs